Should U.S. biotech companies be allowed to sell to China's police force?
On December 13, 2019, in a cavernous meeting hall in the Chinese seaside city of Xiamen, Richard Selden took the stage to show off his company’s revolutionary technology: rapid DNA testing.
Top: Richard Selden delivers a presentation on the ANDE device, December 13, 2019. Bottom: Conference attendees examine ANDE's machine. Credit: 邯郸网警
Wearing a red tie that matched the decor, Selden, the founder of ANDE, explained how the large black box can take a single sample and deliver acc
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Novo Nordisk, the maker of Ozempic, has enjoyed a China boom in recent years, commanding 77 percent of the market. But that kind of dominance isn’t likely to last, and Novo Nordisk’s challengers in China...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy